134 related articles for article (PubMed ID: 14527758)
1. Respiratory tract secretions in the dying patient: a retrospective study.
Kåss RM; Ellershaw J
J Pain Symptom Manage; 2003 Oct; 26(4):897-902. PubMed ID: 14527758
[TBL] [Abstract][Full Text] [Related]
2. Respiratory tract secretions in the dying patient: a comparison between glycopyrronium and hyoscine hydrobromide.
Hugel H; Ellershaw J; Gambles M
J Palliat Med; 2006 Apr; 9(2):279-84. PubMed ID: 16629557
[TBL] [Abstract][Full Text] [Related]
3. A pilot phase II randomized, cross-over, double-blinded, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end-of-life.
Clark K; Currow DC; Agar M; Fazekas BS; Abernethy AP
J Pain Palliat Care Pharmacother; 2008; 22(2):131-8. PubMed ID: 19042837
[TBL] [Abstract][Full Text] [Related]
4. Death rattle: an audit of hyoscine (scopolamine) use and review of management.
Bennett MI
J Pain Symptom Manage; 1996 Oct; 12(4):229-33. PubMed ID: 8898506
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and narrative summary: Treatments for and risk factors associated with respiratory tract secretions (death rattle) in the dying adult.
Kolb H; Snowden A; Stevens E
J Adv Nurs; 2018 Jul; 74(7):1446-1462. PubMed ID: 29495089
[TBL] [Abstract][Full Text] [Related]
6. Care of the dying: setting standards for symptom control in the last 48 hours of life.
Ellershaw J; Smith C; Overill S; Walker SE; Aldridge J
J Pain Symptom Manage; 2001 Jan; 21(1):12-7. PubMed ID: 11223310
[TBL] [Abstract][Full Text] [Related]
7. A retrospective medical records review of risk factors for the development of respiratory tract secretions (death rattle) in the dying patient.
Kolb H; Snowden A; Stevens E; Atherton I
J Adv Nurs; 2018 Jul; 74(7):1639-1648. PubMed ID: 29741782
[TBL] [Abstract][Full Text] [Related]
8. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care.
Wildiers H; Dhaenekint C; Demeulenaere P; Clement PM; Desmet M; Van Nuffelen R; Gielen J; Van Droogenbroeck E; Geurs F; Lobelle JP; Menten J;
J Pain Symptom Manage; 2009 Jul; 38(1):124-33. PubMed ID: 19361952
[TBL] [Abstract][Full Text] [Related]
9. Death rattle: prevalence, prevention and treatment.
Wildiers H; Menten J
J Pain Symptom Manage; 2002 Apr; 23(4):310-7. PubMed ID: 11997200
[TBL] [Abstract][Full Text] [Related]
10. [Frequency of symptoms and drug treatment among dying patients in the last 24 hours of life at Landspitali - The National University Hospital of Iceland and in nursing homes].
Halfdanardottir SI; Olafsdottir KL; Sigurdardottir V
Laeknabladid; 2017 Mai; 103(5):223-228. PubMed ID: 28489007
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergic agents for the treatment of "death rattle" in patients with myasthenia gravis.
Spiess JL; Scott SD
J Pain Symptom Manage; 2003 Jul; 26(1):684-6. PubMed ID: 12850651
[TBL] [Abstract][Full Text] [Related]
12. Hyoscine vs glycopyrronium for drying respiratory secretions in dying patients.
Lawrey H
Br J Community Nurs; 2005 Sep; 10(9):421-4, 426. PubMed ID: 16234752
[TBL] [Abstract][Full Text] [Related]
13. Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion.
Lindqvist O; Lundquist G; Dickman A; Bükki J; Lunder U; Hagelin CL; Rasmussen BH; Sauter S; Tishelman C; Fürst CJ;
J Palliat Med; 2013 Jan; 16(1):38-43. PubMed ID: 23234300
[TBL] [Abstract][Full Text] [Related]
14. Identifying palliative care issues in inpatients dying following stroke.
Ntlholang O; Walsh S; Bradley D; Harbison J
Ir J Med Sci; 2016 Aug; 185(3):741-744. PubMed ID: 25851714
[TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of primary diagnosis, comorbidities, anticholinergic load, and other factors on treatment for noisy respiratory secretions at the end of life.
Sheehan C; Clark K; Lam L; Chye R
J Palliat Med; 2011 Nov; 14(11):1211-6. PubMed ID: 21883008
[TBL] [Abstract][Full Text] [Related]
16. [Palliative care for patients with COPD: a challenge].
du Couëdic L; Morel V; Trehello L; Trehony A; Robert M; Sandron D
Rev Mal Respir; 2012 Nov; 29(9):1088-94. PubMed ID: 23200580
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergic medications for managing noisy respirations in adult hospice patients.
Kintzel PE; Chase SL; Thomas W; Vancamp DM; Clements EA
Am J Health Syst Pharm; 2009 Mar; 66(5):458-64. PubMed ID: 19233993
[TBL] [Abstract][Full Text] [Related]
18. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle.
Back IN; Jenkins K; Blower A; Beckhelling J
Palliat Med; 2001 Jul; 15(4):329-36. PubMed ID: 12054150
[TBL] [Abstract][Full Text] [Related]
19. The use of Scopoderm in palliative care.
Spiller JA; Fallon M
Hosp Med; 2000 Nov; 61(11):782-4. PubMed ID: 11198747
[TBL] [Abstract][Full Text] [Related]
20. Atropine eyedrops for death rattle in a terminal cancer patient.
Shinjo T; Okada M
J Palliat Med; 2013 Feb; 16(2):212-3. PubMed ID: 22747099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
